• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SAG/ROC2 E3 连接酶通过对 c-Jun/AP1 和 IkappaB-α/NF-kappaB 的阶段依赖性靶向作用来调节皮肤癌发生。

SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB.

作者信息

Gu Qingyang, Bowden G Tim, Normolle Daniel, Sun Yi

机构信息

Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109, USA.

出版信息

J Cell Biol. 2007 Sep 10;178(6):1009-23. doi: 10.1083/jcb.200612067.

DOI:10.1083/jcb.200612067
PMID:17846172
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2064624/
Abstract

Sensitive to apoptosis gene (SAG)/regulator of cullins-2-Skp1-cullin-F-box protein (SCF) E3 ubiquitin ligase regulates cellular functions through ubiquitination and degradation of protein substrates. We report that, when expressed in mouse epidermis driven by the K14 promoter, SAG inhibited TPA-induced c-Jun levels and activator protein-1 (AP-1) activity in both in vitro primary culture, in vivo transgenic mice, and an AP-1- luciferase reporter mouse model. After AP-1 inactivation, epidermal proliferation induced by 7,12-dimethylbenz(a)-anthracene/12-O-tetradecanoylphorbol-13-acetate at the early stage of carcinogenesis was substantially inhibited. Later stage tumor formation was also substantially inhibited with prolonged latency and reduced frequency of tumor formation. Interestingly, SAG expression increased tumor size, not because of accelerated proliferation, but caused by reduced apoptosis resulting, at least in part, from nuclear factor kappaB (NF-kappaB) activation. Thus, SAG, in a manner depending on the availability of F-box proteins, demonstrated early-stage suppression of tumor formation by promoting c-Jun degradation, thereby inhibiting AP-1, and later-stage enhancement of tumor growth, by promoting inhibitor of kappaBalpha degradation to activate NF-kappaB and inhibit apoptosis.

摘要

凋亡敏感基因(SAG)/Cullin-2调节因子-Skp1-Cullin-F盒蛋白(SCF)E3泛素连接酶通过蛋白质底物的泛素化和降解来调节细胞功能。我们报道,当由K14启动子驱动在小鼠表皮中表达时,SAG在体外原代培养、体内转基因小鼠以及AP-1荧光素酶报告基因小鼠模型中均抑制了佛波酯(TPA)诱导的c-Jun水平和活化蛋白-1(AP-1)活性。AP-1失活后,在致癌作用早期由7,12-二甲基苯并[a]蒽/12-O-十四烷酰佛波醇-13-乙酸酯诱导的表皮增殖受到显著抑制。后期肿瘤形成也受到显著抑制,潜伏期延长且肿瘤形成频率降低。有趣的是,SAG表达增加了肿瘤大小,这并非由于增殖加速,而是至少部分由核因子κB(NF-κB)激活导致的细胞凋亡减少所致。因此,SAG以一种依赖于F盒蛋白可用性的方式,通过促进c-Jun降解从而抑制AP-1,表现出对肿瘤形成的早期抑制作用;又通过促进κBα抑制蛋白降解以激活NF-κB并抑制细胞凋亡,表现出对肿瘤生长的后期增强作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/5294386748fd/jcb1781009f09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/30440665f11d/jcb1781009f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/e633385c1a51/jcb1781009f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/31e1e59f8911/jcb1781009f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/3c1a50b61479/jcb1781009f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/b193969a2f6a/jcb1781009f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/1e5af5daae4b/jcb1781009f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/33e46a4b5054/jcb1781009f07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/40f2d60e403e/jcb1781009f08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/5294386748fd/jcb1781009f09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/30440665f11d/jcb1781009f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/e633385c1a51/jcb1781009f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/31e1e59f8911/jcb1781009f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/3c1a50b61479/jcb1781009f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/b193969a2f6a/jcb1781009f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/1e5af5daae4b/jcb1781009f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/33e46a4b5054/jcb1781009f07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/40f2d60e403e/jcb1781009f08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71df/2064624/5294386748fd/jcb1781009f09.jpg

相似文献

1
SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB.SAG/ROC2 E3 连接酶通过对 c-Jun/AP1 和 IkappaB-α/NF-kappaB 的阶段依赖性靶向作用来调节皮肤癌发生。
J Cell Biol. 2007 Sep 10;178(6):1009-23. doi: 10.1083/jcb.200612067.
2
SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation.SAG/ROC2/Rbx2是一种新型激活蛋白-1靶点,可促进c-Jun降解并抑制12-氧十四烷酰佛波醇-13-乙酸酯诱导的肿瘤转化。
Cancer Res. 2007 Apr 15;67(8):3616-25. doi: 10.1158/0008-5472.CAN-06-4020.
3
SAG/ROC2/RBX2 E3 ligase promotes UVB-induced skin hyperplasia, but not skin tumors, by simultaneously targeting c-Jun/AP-1 and p27.SAG/ROC2/RBX2 E3 连接酶通过同时靶向 c-Jun/AP-1 和 p27,促进紫外线 B 诱导的皮肤增生,但不促进皮肤肿瘤。
Carcinogenesis. 2008 Apr;29(4):858-65. doi: 10.1093/carcin/bgn021. Epub 2008 Feb 6.
4
Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.赭曲霉毒素 A 通过核因子-κB 和激活蛋白-1 激活细胞周期蛋白 D1 和环氧化酶-2 的表达,诱导小鼠皮肤细胞增殖和肿瘤促进。
Carcinogenesis. 2013 Mar;34(3):647-57. doi: 10.1093/carcin/bgs368. Epub 2012 Nov 21.
5
Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-kappaB and AP-1: IkappaB kinase and c-Jun-N-terminal kinase as respective potential upstream targets.蛇麻酮通过阻断核因子-κB(NF-κB)和活化蛋白-1(AP-1)的激活,抑制佛波酯诱导的小鼠皮肤中环氧合酶-2(COX-2)的表达:分别以IκB激酶和c-Jun氨基末端激酶作为潜在的上游靶点。
Carcinogenesis. 2007 Jul;28(7):1491-8. doi: 10.1093/carcin/bgm054. Epub 2007 Mar 19.
6
Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.显性负性激活蛋白1(TAM67)在特异性抑制肿瘤发生的条件下靶向环氧化酶-2和骨桥蛋白。
Cancer Res. 2007 Mar 15;67(6):2430-8. doi: 10.1158/0008-5472.CAN-06-0522.
7
Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.核因子-κB和活化蛋白-1激活的抑制剂均可阻断肿瘤转化反应。
Cancer Res. 1997 Aug 15;57(16):3569-76.
8
Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.转化无反应性细胞的耐药性归因于缺乏p65/核因子-κB激活。
Cancer Res. 2001 May 15;61(10):4160-8.
9
Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase.SAG/RBX2/ROC2/RNF7 的功能特征研究,一种抗氧化蛋白和 E3 泛素连接酶。
Protein Cell. 2013 Feb;4(2):103-16. doi: 10.1007/s13238-012-2105-7. Epub 2012 Nov 8.
10
Disruption of Sag/Rbx2/Roc2 induces radiosensitization by increasing ROS levels and blocking NF-kappaB activation in mouse embryonic stem cells.Sag/Rbx2/Roc2 的破坏通过增加 ROS 水平和阻断 NF-κB 激活来诱导小鼠胚胎干细胞的放射增敏作用。
Free Radic Biol Med. 2010 Sep 15;49(6):976-83. doi: 10.1016/j.freeradbiomed.2010.05.030. Epub 2010 Jun 8.

引用本文的文献

1
[High RNF7 expression enhances PD-1 resistance of non-small cell lung cancer cells by promoting CXCL1 expression and myeloid-derived suppressor cell recruitment activating NF-κB signaling].[高RNF7表达通过促进CXCL1表达和髓系来源抑制细胞募集激活NF-κB信号增强非小细胞肺癌细胞的PD-1抗性]
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Sep 20;44(9):1704-1711. doi: 10.12122/j.issn.1673-4254.2024.09.10.
2
Sag deletion promotes DMBA/TPA-induced skin carcinogenesis via YAP accumulation.Sag缺失通过YAP积累促进DMBA/TPA诱导的皮肤癌发生。
MedComm (2020). 2024 Jul 17;5(8):e648. doi: 10.1002/mco2.648. eCollection 2024 Aug.
3

本文引用的文献

1
SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation.SAG/ROC2/Rbx2是一种新型激活蛋白-1靶点,可促进c-Jun降解并抑制12-氧十四烷酰佛波醇-13-乙酸酯诱导的肿瘤转化。
Cancer Res. 2007 Apr 15;67(8):3616-25. doi: 10.1158/0008-5472.CAN-06-4020.
2
Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role.ERK5和E3泛素连接酶UBR1对c-Fos的时空调节及其生物学作用。
Mol Cell. 2006 Oct 6;24(1):63-75. doi: 10.1016/j.molcel.2006.08.005.
3
Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells.
USP5 facilitates bladder cancer progression by stabilizing the c-Jun protein.
USP5通过稳定c-Jun蛋白促进膀胱癌进展。
Cancer Cell Int. 2024 Jan 16;24(1):32. doi: 10.1186/s12935-024-03222-7.
4
RNF7 Facilitated the Tumorigenesis of Pancreatic Cancer by Activating PI3K/Akt Signaling Pathway.RNF7 通过激活 PI3K/Akt 信号通路促进胰腺癌的发生。
Oxid Med Cell Longev. 2023 Jan 4;2023:1728463. doi: 10.1155/2023/1728463. eCollection 2023.
5
Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the Kras-PDAC model.Sag/Rbx2 E3的转基因表达在Kras-PDAC模型中导致早期肿瘤促进、晚期细胞生成和腺泡丢失。
Neoplasia. 2020 Apr 24;22(6):242-252. doi: 10.1016/j.neo.2020.03.002.
6
Erk1/2 inactivation promotes a rapid redistribution of COP1 and degradation of COP1 substrates.ERK1/2 的失活促进了 COP1 的快速重分布和 COP1 底物的降解。
Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):4078-4087. doi: 10.1073/pnas.1913698117. Epub 2020 Feb 10.
7
Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.通过 COP1/c-Jun/HDAC3 轴增强 PD-L1 启动子上的组蛋白 H3 乙酰化对于耐药癌细胞中 PD-L1 的表达是必需的。
J Exp Clin Cancer Res. 2020 Feb 5;39(1):29. doi: 10.1186/s13046-020-1536-x.
8
SAG expression associates with COPB2-related signaling and a poorer prognosis in breast cancer.SAG 表达与 COPB2 相关信号转导相关,并与乳腺癌的不良预后相关。
Aging (Albany NY). 2020 Jan 11;12(1):902-911. doi: 10.18632/aging.102663.
9
The many substrates and functions of NEDD4-1.NEDD4-1 的多种底物和功能。
Cell Death Dis. 2019 Dec 2;10(12):904. doi: 10.1038/s41419-019-2142-8.
10
The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways.FBXW7-SHOC2-Raptor 轴控制 RAS-ERK 和 mTORC1 信号通路之间的串扰。
Cell Rep. 2019 Mar 12;26(11):3037-3050.e4. doi: 10.1016/j.celrep.2019.02.052.
致癌性BRAF调节人黑素瘤细胞中的β-转导素重复序列包含蛋白(β-Trcp)表达和核因子κB(NF-κB)活性。
Oncogene. 2007 Mar 22;26(13):1954-8. doi: 10.1038/sj.onc.1209994. Epub 2006 Sep 25.
4
E3 ubiquitin ligases as cancer targets and biomarkers.E3泛素连接酶作为癌症靶点和生物标志物。
Neoplasia. 2006 Aug;8(8):645-54. doi: 10.1593/neo.06376.
5
Nuclear factor-kappaB in cancer development and progression.核因子-κB在癌症发生发展中的作用
Nature. 2006 May 25;441(7092):431-6. doi: 10.1038/nature04870.
6
Ubiquitin ligases: cell-cycle control and cancer.泛素连接酶:细胞周期调控与癌症
Nat Rev Cancer. 2006 May;6(5):369-81. doi: 10.1038/nrc1881.
7
Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin.皮肤中α-连环蛋白、核因子κB与鳞状细胞癌之间的联系。
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2322-7. doi: 10.1073/pnas.0510422103. Epub 2006 Feb 1.
8
Mechanisms of tumor suppression by the SCF(Fbw7).SCF(Fbw7)介导的肿瘤抑制机制
Cell Cycle. 2005 Oct;4(10):1356-9. doi: 10.4161/cc.4.10.2058. Epub 2005 Oct 27.
9
The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase.v-Jun点突变使c-Jun能够逃避Fbw7泛素连接酶介导的依赖GSK3的识别和破坏。
Cancer Cell. 2005 Jul;8(1):25-33. doi: 10.1016/j.ccr.2005.06.005.
10
Targeting beta-transducin repeat-containing protein E3 ubiquitin ligase augments the effects of antitumor drugs on breast cancer cells.靶向含β-转导蛋白重复序列的蛋白E3泛素连接酶可增强抗肿瘤药物对乳腺癌细胞的作用。
Cancer Res. 2005 Mar 1;65(5):1904-8. doi: 10.1158/0008-5472.CAN-04-2597.